38 related articles for article (PubMed ID: 8402695)
1. Production and crystallization of the C-propeptide trimer from human procollagen III.
Bourhis JM; Mariano N; Zhao Y; Walter TS; El Omari K; Delolme F; Moali C; Hulmes DJ; Aghajari N
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1209-13. PubMed ID: 23027749
[TBL] [Abstract][Full Text] [Related]
2. Collagen-based three-dimensional culture microenvironment promotes epithelial to mesenchymal transition and drug resistance of human ovarian cancer
Liu M; Zhang X; Long C; Xu H; Cheng X; Chang J; Zhang C; Zhang C; Wang X
RSC Adv; 2018 Feb; 8(16):8910-8919. PubMed ID: 35539845
[TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of different biofluids towards ovarian cancer diagnosis using Raman microspectroscopy.
Giamougiannis P; Morais CLM; Grabowska R; Ashton KM; Wood NJ; Martin-Hirsch PL; Martin FL
Anal Bioanal Chem; 2021 Jan; 413(3):911-922. PubMed ID: 33242117
[TBL] [Abstract][Full Text] [Related]
4. Role of mesenchymal cells in the natural history of ovarian cancer: a review.
Touboul C; Vidal F; Pasquier J; Lis R; Rafii A
J Transl Med; 2014 Oct; 12():271. PubMed ID: 25303976
[TBL] [Abstract][Full Text] [Related]
5. Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion.
Cheung LW; Yung S; Chan TM; Leung PC; Wong AS
Mol Ther; 2013 Jan; 21(1):78-90. PubMed ID: 23164934
[TBL] [Abstract][Full Text] [Related]
6. Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.
Barbolina MV; Liu Y; Gurler H; Kim M; Kajdacsy-Balla AA; Rooper L; Shepard J; Weiss M; Shea LD; Penzes P; Ravosa MJ; Stack MS
J Biol Chem; 2013 Jan; 288(1):141-51. PubMed ID: 23152495
[TBL] [Abstract][Full Text] [Related]
7. Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.
Kenny HA; Dogan S; Zillhardt M; K Mitra A; Yamada SD; Krausz T; Lengyel E
Cancer Treat Res; 2009; 149():335-51. PubMed ID: 19763444
[No Abstract] [Full Text] [Related]
8. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.
Moss NM; Barbolina MV; Liu Y; Sun L; Munshi HG; Stack MS
Cancer Res; 2009 Sep; 69(17):7121-9. PubMed ID: 19706774
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.
Barbolina MV; Adley BP; Kelly DL; Shepard J; Fought AJ; Scholtens D; Penzes P; Shea LD; Stack MS
Int J Cancer; 2009 Aug; 125(4):816-25. PubMed ID: 19382180
[TBL] [Abstract][Full Text] [Related]
10. EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.
Hudson LG; Moss NM; Stack MS
Future Oncol; 2009 Apr; 5(3):323-38. PubMed ID: 19374540
[TBL] [Abstract][Full Text] [Related]
11. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma.
Adley BP; Gleason KJ; Yang XJ; Stack MS
Gynecol Oncol; 2009 Feb; 112(2):319-24. PubMed ID: 18976802
[TBL] [Abstract][Full Text] [Related]
12. Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.
Kennedy A; Dong H; Chen D; Chen WT
Int J Cancer; 2009 Jan; 124(1):27-35. PubMed ID: 18823010
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression in ovarian carcinoma: identification of potential biomarkers.
Hibbs K; Skubitz KM; Pambuccian SE; Casey RC; Burleson KM; Oegema TR; Thiele JJ; Grindle SM; Bliss RL; Skubitz AP
Am J Pathol; 2004 Aug; 165(2):397-414. PubMed ID: 15277215
[TBL] [Abstract][Full Text] [Related]
14. Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo.
Kauppila S; Bode MK; Stenbäck F; Risteli L; Risteli J
Br J Cancer; 1999 Oct; 81(4):654-61. PubMed ID: 10574251
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.
Santala M; Risteli J; Risteli L; Puistola U; Kacinski BM; Stanley ER; Kauppila A
Br J Cancer; 1998 Jun; 77(11):1825-31. PubMed ID: 9667653
[TBL] [Abstract][Full Text] [Related]
16. Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity.
Zhu GG; Risteli J; Puistola U; Kauppila A; Risteli L
Cancer Res; 1993 Oct; 53(20):5028-32. PubMed ID: 8402695
[TBL] [Abstract][Full Text] [Related]
17. Differential processing of type I and type III procollagens in the tumour cysts and peritoneal ascitic fluid of patients with benign and malignant ovarian tumours.
Zhu GG; Melkko J; Risteli J; Kauppila A; Risteli L
Clin Chim Acta; 1994 Sep; 229(1-2):87-97. PubMed ID: 7988058
[TBL] [Abstract][Full Text] [Related]
18. Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas.
Kauppila S; Saarela J; Stenbäck F; Risteli J; Kauppila A; Risteli L
Am J Pathol; 1996 Feb; 148(2):539-48. PubMed ID: 8579116
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
